Begin main content

Yttrium-90 Microsphere Radioembolization for the Treatment of Primary or Secondary Liver Cancer: Clinical Effectiveness, Cost-Effectiveness, and Guidelines

Last updated: February 24, 2016
Project Number: RB0963-000
Product Line: Rapid Response
Research Type: Devices and Systems
Report Type: Summary of Abstracts
Result type: Report

Question

  1. What is the clinical effectiveness of Yttrium-90 microsphere radioembolization for the treatment of primary or secondary liver tumors?
  2. What is the cost-effectiveness of Yttrium-90 microsphere radioembolization for the treatment of primary or secondary liver tumors?
  3. What are the evidence-based guidelines regarding Yttrium-90 microsphere radioembolization for the treatment of primary or secondary liver tumors?

Key Message

Eleven systematic reviews/meta-analyses and two economic evaluations were identified regarding the clinical and cost-effectiveness of Yttrium-90 microsphere radioembolization for the treatment of primary or secondary liver cancer.